Clinical Report: A Systematic Review of Perioperative Strategies in RRRC

Overview

This systematic review evaluates perioperative strategies and outcomes for patients with re-recurrent rectal cancer (RRRC) undergoing curative-intent treatment. The findings highlight the variability in treatment approaches.

Background

Re-recurrent rectal cancer (RRRC) is a complex condition that arises after prior treatments for recurrent rectal cancer (RRC). Despite the existence of management guidelines for primary and locally recurrent rectal cancer, there are currently no specific recommendations for the perioperative management of RRRC.

Data Highlights

Key Findings

• Neoadjuvant therapy was administered to 20–92% of patients based on prior radiation doses.
• Total pelvic exenteration was performed in 6–20% of cases.
• Sacrectomy was required in up to 15% of patients.
• Intraoperative radiotherapy (IORT) was utilized in 44–77% of patients where available.
• R0 resection rates varied from 33% to 62%, significantly impacting oncological outcomes.

Clinical Implications

The findings indicate variability in management strategies.

Conclusion

This systematic review highlights the complexity of managing RRRC.

Related Resources & Content

1. Surgical Endoscopy, 2026 -- Transanal endoscopic microsurgery was associated with higher recurrence rate in both low- and high-risk T1 rectal cancer compared to surgical resection
2. A Systematic Review and Meta-Analysis of Perineal Versus Abdominal Surgical Techniques for Recurrent External Rectal Prolapse, 2024
3. Impact of Initial Treatment Strategies on Prognosis Following Recurrence in Locally Advanced Rectal Cancer: Findings from a Retrospective Cohort Study, 2024
4. Techniques in Coloproctology -- Comparative Outcomes of Laparoscopic versus Open Surgery for Rectal Cancer: A Systematic Review and Meta-Analysis of Short- and Long-Term Oncological Results
5. Frontiers | Current evidence on the management of Re-Recurrent Rectal Cancer: A systematic review
6. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer, 2024
7. ESTRO recommendations for the use, planning and delivery of reirradiation in locally recurrent rectal cancer – Endorsed by ASTRO
8. Frontiers | Current evidence on the management of Re-Recurrent Rectal Cancer: A systematic review
9. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer - - 2024 - Colorectal Disease - Wiley Online Library
10. ESTRO recommendations for the use, planning and delivery of reirradiation in locally recurrent rectal cancer – Endorsed by ASTRO - ScienceDirect